Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome

West Indian Medical Journal

Volumn 61, Issue 6, 2012, Pages

  Kosan C ^a   Ayar, G ^a   Orbak, Z ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Bone mineral density; Children; Glucocorticoid; Nephrotic syndrome

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PREDNISOLONE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; CLINICAL ARTICLE; CREATININE URINE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOCORTICOID SENSITIVE NEPHROTIC SYNDROME; HUMAN; MALE; MORNING DOSAGE; NEPHROTIC SYNDROME; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; SCHOOL CHILD; SINGLE DRUG DOSE;

EID: 84872519101     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Olgaard K, Storm T, van Wovern N, Daugaard H, Egfjord M, Lewin E et al. Glucocorticoid induced osteoporosis in lumbar spine, forearm and mandible of nephrotic patients: a double blind study on the high dose long term effects of prednisolone versus deflazocort. Calcif Tissue Int 1992; 50: 490-7.
2. Yildirim ZK, Buyukavci M, Eren S, Orbak Z, Sahin A, Karakelleoglu C. Late-side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 749-53.
3. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 2004; 351: 868-75.
4. Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 2006; 21: 350-4.
5. Esbjörner E, Arvidsson B, Jones IL, Palmer M. Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatr 2001; 90: 1127-30.
6. Eastell R. Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med 1995; 237: 439-47.
7. Elder GJ. Nephrotic syndrome: don't forget the bones!. Nephrology 2008; 13: 43-4.
8. van Hoof HJ, de Sevaux RG, van Baelen H, Swinkels LM, Klipping C, Ross HA et al. Relationship between free and total 1,25-dihydroxyvitamin D in contributions of modified binding. Eur J Endocrinol 2001; 144: 391-6.
9. Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006; 39: 561-8.
10. Biyikli NK, Emre S, Sirin A, Bilge I. Biochemical bone markers in nephrotic children. Pediatr Nephrol 2004; 19: 869-73.
11. Lems WF, Gerrits MI, Jacobs JW, van Vugt RM, van Rijn HJ, Bijlsma JW. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum 1996; 55: 288-93.
12. Orbak Z, Selimoglu A, Doneray H. Inherited vitamin K deficiency: case report and review of literature. Yonsei Med J 2003; 44: 923-7.
13. Freundlich M, Bourgoignie JJ, Zilleruelo G, Abitbol C, Canterbury JM, Strauss J. Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr 1986; 108: 383-7.
14. Sierra RI, Specker BL, Jimenez F, Cruz C, Pedraza-Chaverri J. Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome. Ren Fail 1997; 19: 409-24